3-deazaneplanocin has been researched along with Biliary Tract Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berr, F; Di Fazio, P; Illig, R; Jakab, M; Kiesslich, T; Mayr, C; Neureiter, D; Ocker, M; Pichler, M; Stoecklinger, A; Wagner, A | 1 |
1 other study(ies) available for 3-deazaneplanocin and Biliary Tract Cancer
| Article | Year |
|---|---|
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.
Topics: Adenosine; Biliary Tract Neoplasms; Biomarkers, Tumor; Cell Death; Cell Line, Tumor; Cell Survival; Cyclins; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells; Polycomb Repressive Complex 2; RNA, Messenger | 2015 |